Patents by Inventor Andreas Rohrwasser

Andreas Rohrwasser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
    Patent number: 7749725
    Abstract: The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
    Type: Grant
    Filed: October 16, 2002
    Date of Patent: July 6, 2010
    Assignee: University of Utah Research Foundation
    Inventors: Andreas Rohrwasser, Terry Morgan, Jean-Marc Lalouel
  • Molecular variants, haplotypes and linkage disequilibrium within the human angiotensinogen gene
    Publication number: 20030219776
    Abstract: The present invention relates to methods for assessing risk of hypertension in als by identifying the molecular variants or haplotypes of the angiotensinogen (AGT) gene.
    Type: Application
    Filed: December 18, 2002
    Publication date: November 27, 2003
    Inventors: Jean-Marc Lalouel, Andreas Rohrwasser, Tomoaki Ishigami, Mitsuru Emi, Toshiaki Nakajima, Ituro Inoue
  • Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
    Publication number: 20030036208
    Abstract: The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
    Type: Application
    Filed: October 16, 2002
    Publication date: February 20, 2003
    Applicant: University of Utah Research Foundation, a Utah corporation
    Inventors: Andreas Rohrwasser, Terry Morgan, Jean-Marc Lalouel
  • Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
    Patent number: 6495338
    Abstract: The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: December 17, 2002
    Assignee: University of Utah Research Foundation
    Inventors: Andreas Rohrwasser, Terry Morgan, Jean-Marc Lalouel
  • Method to determine predisposition to hypertension
    Patent number: 6177252
    Abstract: The T/C(67) AGT gene variant and the association of the molecular variant C(67) with predisposition of an individual to hypertension are disclosed. The determination of this association enables the screening of persons to identify the severity of hypertension or the severity of the risk of a predisposition to high blood pressure.
    Type: Grant
    Filed: August 27, 1999
    Date of Patent: January 23, 2001
    Assignee: University of Utah Research Foundation
    Inventors: Andreas Rohrwasser, Jean-Marc Lalouel